دورية أكاديمية

Local injury and systemic infection in infants alter later nociception and pain affect during early life and adulthood.

التفاصيل البيبلوغرافية
العنوان: Local injury and systemic infection in infants alter later nociception and pain affect during early life and adulthood.
المؤلفون: Gomes CI; Department of Neonatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Barr GA; Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, 3615 Civic Center Boulevard, Philadelphia, PA, 19104, USA.; Department of Psychology, University of Pennsylvania, 425 S. University Avenue, Stephen A. Levin Building, Philadelphia, PA, USA.
المصدر: Brain, behavior, & immunity - health [Brain Behav Immun Health] 2020 Nov 10; Vol. 9, pp. 100175. Date of Electronic Publication: 2020 Nov 10 (Print Publication: 2020).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101759062 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3546 (Electronic) Linking ISSN: 26663546 NLM ISO Abbreviation: Brain Behav Immun Health Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [New York] : Elsevier Inc., [2020]-
مستخلص: Newborns in intensive care are regularly exposed to minor painful procedures at developmental time points when noxious stimulation would be normally absent. Pain from these interventions is inconsistently treated and often exists concurrently with systemic infection, a common comorbidity of prematurity. Our understanding of the independent and combined effects of early painful experiences and infection on pain response is incomplete. The main goals of this research therefore were to understand how pain and infection experienced early in life influence future nociceptive and affective responses to painful stimuli. Rat pups were infected with E-coli on postnatal day 2 (PN2) and had left hind paw injury with carrageenan on PN3. Standard thermal tests for acute pain, formalin tests for inflammatory pain, and conditioned place aversion testing were performed at different ages to assess the nociceptive and affective components of the pain response. Early E-coli infection and early inflammatory injury with carrageenan both independently increased pain scores following hind paw reinjury with formalin on PN8, with effects persisting into adulthood in the carrageenan exposed group. When experienced concurrently, early E-coli infection and carrageenan exposure also increased conditioned aversion to pain in adults. Effect of sex was significant only in formalin testing, with males showing higher pain scores in infancy and females showing higher pain scores as adults. These findings demonstrate that infection experienced early in life can alter both the nociceptive and affective components of the pain response and that there is a cumulative effect of local and systemic pro-inflammatory processes on the aversive component of pain.
Competing Interests: The authors have no conflicts of interest to disclose.
(© 2020 The Authors.)
References: Pain. 1994 Jan;56(1):95-101. (PMID: 8159446)
Neuroreport. 2001 Feb 12;12(2):399-403. (PMID: 11209957)
Behav Neurosci. 2005 Feb;119(1):293-301. (PMID: 15727533)
Pediatrics. 2016 Dec;138(6):. (PMID: 27940705)
Neuroscience. 2016 Dec 3;338:207-219. (PMID: 27457037)
Front Neuroendocrinol. 2012 Aug;33(3):267-86. (PMID: 22982535)
Psychoneuroendocrinology. 2014 Mar;41:1-12. (PMID: 24495603)
Dev Psychobiol. 2003 Mar;42(2):111-22. (PMID: 12555276)
J Nutr. 1998 Mar;128(3):661-3. (PMID: 9482778)
Sci Rep. 2016 Dec 14;6:39159. (PMID: 27966656)
PLoS One. 2014 May 30;9(5):e98382. (PMID: 24878577)
Biol Neonate. 1998;73(1):1-9. (PMID: 9458936)
J Neurosci. 2013 Apr 24;33(17):7368-83. (PMID: 23616543)
Pharmacol Biochem Behav. 1997 Aug;57(4):779-83. (PMID: 9259006)
Physiol Behav. 1999 Jun;66(4):627-37. (PMID: 10386907)
Pediatrics. 2000 Jan;105(1):e6. (PMID: 10617743)
JAMA. 2008 Jul 2;300(1):60-70. (PMID: 18594041)
PLoS One. 2012;7(3):e34316. (PMID: 22470556)
Genes Brain Behav. 2013 Oct;12(7):673-80. (PMID: 23927771)
Int J Dev Neurosci. 2004 Aug-Oct;22(5-6):415-22. (PMID: 15380840)
J Neurosci. 2018 Jan 24;38(4):878-886. (PMID: 29255007)
J Perinatol. 2013 Aug;33(8):647-51. (PMID: 23558431)
Science. 2000 Jul 28;289(5479):628-31. (PMID: 10915627)
Front Neurol. 2018 Sep 07;9:743. (PMID: 30245664)
Lancet. 1997 Mar 1;349(9052):599-603. (PMID: 9057731)
Clin Perinatol. 2002 Sep;29(3):357-72. (PMID: 12380463)
J Neurosci. 2005 Aug 31;25(35):8000-9. (PMID: 16135757)
Front Neurosci. 2015 Mar 10;9:65. (PMID: 25805965)
Life Sci. 1985 Jan 28;36(4):363-8. (PMID: 3965852)
Brain Behav Immun. 2017 Jul;63:148-159. (PMID: 27742580)
Cereb Cortex. 2017 Nov 1;27(11):5274-5283. (PMID: 27799276)
Curr Opin Behav Sci. 2017 Apr;14:78-85. (PMID: 28239630)
Pain. 2004 Aug;110(3):588-596. (PMID: 15288399)
Psychoneuroendocrinology. 2016 Oct;72:161-5. (PMID: 27428089)
Pain Manag. 2014 Jan;4(1):57-67. (PMID: 24641344)
Neurology. 2013 Dec 10;81(24):2082-9. (PMID: 24212394)
PLoS One. 2013 Sep 16;8(9):e73926. (PMID: 24066085)
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9894-9. (PMID: 17535900)
J Matern Fetal Neonatal Med. 2009 Sep;22(9):722-32. (PMID: 19526425)
Int J Dev Neurosci. 2009 Jun;27(4):399-405. (PMID: 19460635)
Pain. 1992 Oct;51(1):81-90. (PMID: 1454409)
Dev Neurobiol. 2015 Oct;75(10):1068-79. (PMID: 25205468)
Clin Perinatol. 2002 Sep;29(3):373-94, vii-viii. (PMID: 12380464)
J Pain. 2004 Oct;5(8):440-9. (PMID: 15501426)
Psychopharmacology (Berl). 1994 Jan;113(3-4):422-8. (PMID: 7862854)
Clin Perinatol. 2013 Sep;40(3):471-91. (PMID: 23972752)
Semin Fetal Neonatal Med. 2006 Aug;11(4):268-75. (PMID: 16632415)
Prog Neurobiol. 2013 Jul-Aug;106-107:1-16. (PMID: 23583307)
Pain. 1988 Jan;32(1):77-88. (PMID: 3340425)
Birth Defects Res B Dev Reprod Toxicol. 2013 Apr;98(2):200-5. (PMID: 23526690)
Early Hum Dev. 2017 Jun;109:1-5. (PMID: 28399457)
Brain Res Dev Brain Res. 1992 Mar 20;66(1):133-6. (PMID: 1600627)
Nat Rev Neurosci. 2005 Jul;6(7):507-20. (PMID: 15995722)
Lancet. 1995 Feb 4;345(8945):291-2. (PMID: 7837863)
Clin Perinatol. 2000 Jun;27(2):363-79. (PMID: 10863655)
Curr Opin Behav Sci. 2019 Aug;28:85-92. (PMID: 32190717)
APMIS. 1997 Mar;105(3):187-91. (PMID: 9137513)
Int Rev Neurobiol. 2009;85:135-44. (PMID: 19607966)
Psychoneuroendocrinology. 2008 Apr;33(3):261-9. (PMID: 18164556)
Psychoneuroendocrinology. 2015 Jan;51:151-63. (PMID: 25313535)
Semin Perinatol. 2007 Oct;31(5):275-82. (PMID: 17905181)
Dev Psychobiol. 1973 Jul;6(4):329-35. (PMID: 4793362)
PLoS One. 2013 Oct 18;8(10):e76702. (PMID: 24204657)
Pediatrics. 2014 Mar;133(3):412-21. (PMID: 24534406)
Pain. 2009 Jul;144(1-2):43-8. (PMID: 19329255)
Dev Neurosci. 2013;35(4):326-37. (PMID: 23838073)
Brain Behav Immun. 2015 Feb;44:235-46. (PMID: 25449583)
Clin Perinatol. 2002 Sep;29(3):395-414. (PMID: 12380465)
Pharmacol Biochem Behav. 1998 Jun;60(2):329-35. (PMID: 9632214)
Clin J Pain. 2015 Apr;31(4):355-62. (PMID: 24866853)
Pediatrics. 2016 Feb;137(2):e20154271. (PMID: 26810788)
Pain. 2008 Jul 31;137(3):473-477. (PMID: 18583048)
Pediatrics. 2011 May;127(5):817-26. (PMID: 21518717)
Toxicology. 2011 Jan 11;279(1-3):123-9. (PMID: 20937348)
Early Hum Dev. 2007 May;83(5):341-8. (PMID: 16979857)
JAMA. 2002 Aug 21;288(7):857-61. (PMID: 12186603)
Ann N Y Acad Sci. 2013 Mar;1279:97-102. (PMID: 23531007)
Toxicol Lett. 2007 Nov 1;174(1-3):18-24. (PMID: 17900830)
Arch Pediatr Adolesc Med. 1998 Jan;152(1):35-40. (PMID: 9452705)
Neurosci Lett. 2006 Aug 7;403(3):222-6. (PMID: 16782271)
Handb Exp Pharmacol. 2015;227:261-84. (PMID: 25846623)
Nature. 2000 Sep 7;407(6800):38-9. (PMID: 10993064)
Pediatr Infect Dis J. 2006 Oct;25(10):939-40. (PMID: 17006292)
ILAR J. 2006;47(1):5-14. (PMID: 16391426)
Dev Psychobiol. 2005 Nov;47(3):230-42. (PMID: 16252291)
Pain. 2007 Nov;132 Suppl 1:S124-S133. (PMID: 17904745)
Physiol Behav. 2003 Mar;78(3):375-83. (PMID: 12676272)
Dev Psychobiol. 2014 Dec;56(8):1698-710. (PMID: 24910104)
Elife. 2015 Apr 21;4:. (PMID: 25895592)
PLoS One. 2013;8(2):e57608. (PMID: 23437400)
Front Neurol. 2016 Dec 15;7:223. (PMID: 28018284)
فهرسة مساهمة: Keywords: Carrageenan; Conditioned place aversion; E-Coli; Formalin test; Ontogeny; Sensitive period
تواريخ الأحداث: Date Created: 20210930 Latest Revision: 20211001
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8474633
DOI: 10.1016/j.bbih.2020.100175
PMID: 34589906
قاعدة البيانات: MEDLINE
الوصف
تدمد:2666-3546
DOI:10.1016/j.bbih.2020.100175